bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today shared another compelling patient case study in which ...
Blood cancer is a serious and long-term condition that affects not only the body but also a patient’s mental and emotional ...
Case Demonstrates Benefit of Integrating CyPath® Lung into Standard of Care for Patients Under Surveillance After Treatment for Previous Lung Cancer SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity ...
MedPage Today on MSN
Gastric cancer's individualized patient-centered treatment approach
The only potentially curative options for gastric cancer involve endoscopic or surgical resection, with adjunctive systemic ...
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released three additional case studies – ...
Scaling back treatment for three kinds of cancer can make life easier for patients without compromising outcomes, doctors reported at the world’s largest cancer conference. It’s part of a long-term ...
High doses of vitamin C could be a new breakthrough in treating cancer. The University of Iowa Health Care Carver College of Medicine has shared results from a randomized, phase 2 trial testing the ...
New Medicaid eligibility rules may cause more than a million missed cancer screenings, and more than 100 preventable deaths, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback